Pro Medicus Limited (AU:PME) has released an update.
Pro Medicus Limited reported a significant financial performance for the full year ending June 2024, with net profit soaring 36.5% to $82.8 million and revenue climbing 29.3% to $161.5 million, underpinned by robust growth in North America and consistent cash reserves. The health imaging company also declared a debt-free status and rewarded shareholders with a 22c per share fully franked final dividend, marking a strong year of contract wins and industry-leading EBIT margins.
For further insights into AU:PME stock, check out TipRanks’ Stock Analysis page.
